InterCare DX, Inc. (ICCO) 股价表现
查看InterCare DX, Inc.股价及公司表现,包括市值,涨跌幅,市盈率,以及历史及当前股价。
昨收 0.00
52周最高 0.00
今开 0.00
52周最低 0.00
振幅 0.00%
市盈率 0%
成交额
0.00
亿
市净率 0%
换手率 0.00%
总市值
0.00亿
股息 0
总股本
0.74
亿
股息收益率 0%
每手股数 1
InterCare DX, Inc.公司介绍
InterCare Dx, Inc., is a USFDA registered biomedical and life sciences company with main office located at 20300 South Vermont Avenue, Suite 215, Torrance, California, USA, and international partners located worldwide.We have also developed an Integrated, web-enabled applications target towards (a) Education Management, (b) Hospitality Management,(c) Legal System Management,(d) Human Capital Management and (e) Healthcare Management industry markets. In addition, we designed, developed and commercialized the "The Mirage Systems Biofeedback and Self Regulation Software Program", the first USFDA approved Software only biofeedback program for clinical use. This product was licensed to United States Navy Submarine division in San Diego California in 1995 and a research center in Germany We have also Commercialized "Vascular Diagnostic Center (Vasocor Model 300)", a freestanding diagnostic device that employs a revolutionary non-invasive, inexpensive, easy-to- use procedure that has been clinically proven to detect coronary artery disease ("CAD") earlier and more accurately than existing techniques. Users include primary care physicians, cardiologists, vascular specialists, clinics, and hospitals. The device is simple enough to be operated by non-physicians and non-nurses. Further, the Vasocor device has FDA approval, validated clinical trial data and qualified for Medicare reimbursement.